Across its top 6 institutional holders, CPHI's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 5/100, avg. turnover score 35/100).

Quarterly Activity

Recent Activity

+$15.5K

Total Buy Value

$21.7K

Total Sell Value

New buy2

Trim1

Add1

Sold out1

Net Buyers

Net Sellers

Smart Money Convergence

CPHI does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/CPHI

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-22

2026-07-22

On July 22, 2026, China Pharma Holdings (CPHI) entered into a securities purchase agreement with an institutional investor to sell 2.5 million shares of common stock at $2 per share, raising roughly $5 million in gross proceeds before fees. The registered direct offering is expected to close on July 23. Under the deal, the investor gets participation rights in certain future financings for three months after closing, and CPHI is restricted from issuing certain securities for 91 days. FT Global Capital acted as exclusive placement agent and will receive a 7% cash commission.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

16941T401

FAQ

Who are the top institutional investors holding CHINA PHARMA HOLDINGS INC (CPHI)?

Major stakeholders currently include Citadel Advisors LLC ($7.9K), Renaissance Technologies LLC ($7.0K), Citigroup INC ($608.0). Based on the latest 13F filings, there are a total of 6 tracked investment funds and institutions maintaining positions in CPHI.

What is the overall institutional sentiment toward CPHI recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.4K, driven by 3 managers accumulating shares while 2 reduced their exposure.

Which institutions have been selling or reducing their CPHI positions?

In the latest period, 1 funds trimmed their holdings, and 1 managers completely exited their positions. The aggregate reported sell value was $21.7K.

Are there any notable investors adding CPHI to their portfolios?

Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $15.5K.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access CPHI's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/CPHI

CLI

npx alphasmo stocks get CPHI

Full API & MCP documentation →